Late onset hypogonadism in males - Think of it - Act on it

International Journal of Clinical Practice

Volumn 66, Issue 2, 2012, Pages 115-116

  Jackson, Graham ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROLACTIN; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGE DISTRIBUTION; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; CANCER RISK; CARDIOVASCULAR RISK; CLINICAL EVALUATION; DIET THERAPY; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; EDITORIAL; ERECTILE DYSFUNCTION; ERYTHROCYTOSIS; EXERCISE; FLUID RETENTION; GLYCEMIC CONTROL; HUMAN; HYPOGONADISM; INSULIN RESISTANCE; LIBIDO DISORDER; MALE; MEN'S HEALTH; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATIENT MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP APNEA SYNDROME; STEROID ANALYSIS; TESTOSTERONE BLOOD LEVEL; THERAPY EFFECT;

AGED; HUMANS; HYPOGONADISM; MALE; TESTOSTERONE;

EID: 84856098953     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02865.x     Document Type: Editorial

References (8)

1. White A, DeSousa B, De Visser R, et al., Men's health in Europe. J Mens Health 2011; 8: 192-201.
2. Wang C,. Eur J Endocrinol 2008; 159: 507-14.
3. Buvat J, Maggi M, Gooren L, et al., Endocrine aspects of male sexual dysfunctions. J Sex Med 2010; 7 (4 Pt 2): 1627-56.
4. Ohlsson C, Barrett-Connor E, Bhasin S, et al., High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol 2011; 58: 1674-81.
5. Kapoor D, Goodwin E, Channer KS, Jones TH,. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006; 154: 899-906. (Pubitemid 43997730)
6. Heufelder AE, Saad F, Bunck MC, Gooren L,. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 2009; 30: 726-33.
7. Jones TH, Arver S, Behre HM, et al., Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 2011; 34: 828-37.
8. Wang C, Jackson G, Jones TH, et al., Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care 2011; 34: 1669-75.